<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03513640</url>
  </required_header>
  <id_info>
    <org_study_id>1705-073-853</org_study_id>
    <nct_id>NCT03513640</nct_id>
  </id_info>
  <brief_title>Risk Factors of Meconium Obstruction and Respiratory Distress Syndrome in Preterm Infants</brief_title>
  <official_title>Prospective Cohort for Finding Risk Factors of Meconium Obstruction and Respiratory Distress Syndrome in Preterm Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although the pathophysiology of meconium obstruction of prematurity (MOP) is not clear, it is&#xD;
      known that the decrease of the intestinal peristalsis due to decreased intestinal perfusion&#xD;
      during antenatal or perinatal period. Recently, the level of citrulline has been used as an&#xD;
      index of function and injury of the small intestine State. This study aimed to evaluate&#xD;
      citrulline level of cord blood as a marker for early detection and observe changes in&#xD;
      intestinal blood flow in MOP patient.&#xD;
&#xD;
      And We aimed to confirm the efficacy of the AT/ET ratio (ratio of the pulmonary artery&#xD;
      time-to-peak velocity interval to the right ventricular ejection time) of the prenatal&#xD;
      pulmonary artery as a noninvasive predictor of neonatal respiratory distress syndrome.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 13, 2018</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of citrulline level between the meconium obstruction group and the normal feeding advance group</measure>
    <time_frame>within 6 hours after birth</time_frame>
    <description>check the citrulline llevel from blood at birth</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of prenatal AT/ET ratio of fetal pulmonary artery between respiratory distress syndrome group and the normal respiration group</measure>
    <time_frame>within 10 days before delivery</time_frame>
    <description>Check the AT/ET ratio of fetal pulmonary artery within 10 days before birth</description>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Meconium Obstruction of Prematurity</condition>
  <condition>Respiratory Distress Syndrome in Premature Infant</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sample at birth for citrulline level analysis urine sample at the first day of life for&#xD;
      fatty acid binding protein analysis&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Premature infants born less than 34 weeks who were admitted in neonatal intensive care unit&#xD;
        at Seoul National University Children's Hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  premature infants born less than 34 weeks from mother with pregnancy induced&#xD;
             hypertension, pre-eclampsia or eclampsia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  major congenital anomalies&#xD;
&#xD;
          -  infants with hypotension while using inotropics&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>34 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Seung Han Shin, M.D.</last_name>
    <phone>+82220727230</phone>
    <email>revival421@snu.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ee-Kyung Kim, PhD.</last_name>
    <phone>+82220723628</phone>
    <email>kimek@snu.ac.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seung Han Shin, MD</last_name>
      <phone>82220727230</phone>
      <email>revival421@snu.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Ee-Kyung Kim, PhD</last_name>
      <phone>82220723628</phone>
      <email>kimek@snu.ac.kr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 19, 2018</study_first_submitted>
  <study_first_submitted_qc>April 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2018</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Ee-Kyung Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meconium Ileus</mesh_term>
    <mesh_term>Intestinal Obstruction</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Respiratory Distress Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Fetal Diseases</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

